The potential of pH-responsive PEG-hyperbranched polyacylhydrazone micelles for cancer therapy

Biomaterials

Volumn 35, Issue 9, 2014, Pages 3132-3144

  Yu, Jingshuang ^a   Deng, Hongping ^b   Xie, Furong ^a   Chen, Wantao ^a   Zhu, Bangshang ^b   Xu, Qin ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Drug delivery; Hyperbranched polymers; PH responsive

Indexed keywords

DRUG DELIVERY; HYPERBRANCHED POLYMERS; PH-RESPONSIVE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; EXTRACELLULAR SPACE; HUMANS; HYDRAZONES; HYDROGEN-ION CONCENTRATION; INTRACELLULAR SPACE; MALE; MICE; MICE, NUDE; MICELLES; NEOPLASMS; POLYETHYLENE GLYCOLS; POLYMERS; TAXOIDS; TISSUE DISTRIBUTION;

EID: 84894965908     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.12.074     Document Type: Article

References (47)

1. Orive G., Hernández R.M., Rodríguez Gascón A., Domínguez-Gil A., Pedraz J.L. Drug delivery in biotechnology: present and future. Curr Opin Biotechnol 2003, 14:659-664.
2. Gong J., Chen M., Zheng Y., Wang S., Wang Y. Polymeric micelles drug delivery system in oncology. JControl Release 2012, 159:312-323.
3. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
4. Qiu L.Y., Bae Y.H. Polymer architecture and drug delivery. Pharm Res 2006, 23:1-30.
5. van Vlerken L.E., Amiji M.M. Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opin Drug Deliv 2006, 3:205-216.
6. Sharma K., Zolotarskaya O.Y., Wynne K.J., Yang H. Poly (ethylene glycol)-armed hyperbranched polyoxetanes for anticancer drug delivery. JBioact Compat Polym 2012, 27:525-539.
7. Paleos C.M., Tsiourvas D., Sideratou Z., Tziveleka L.A. Drug delivery using multifunctional dendrimers and hyperbranched polymers. Expert Opin Drug Deliv 2010, 7:1387-1398.
8. Rahbek U.L., Nielsen A.F., Dong M., You Y., Chauchereau A., Oupicky D., et al. Bioresponsive hyperbranched polymers for siRNA and miRNA delivery. JDrug Target 2010, 18:812-820.
9. Wang Q., Zhu L., Li G., Tu C., Pang Y., Jin C., et al. Doubly hydrophilic multiarm hyperbranched polymers with acylhydrazone linkages as acid-sensitive drug carriers. Macromol Biosci 2011, 11:1553-1562.
10. Xu S., Luo Y., Haag R. Water-soluble pH-responsive dendritic core-shell nanocarriers for polar dyes based on poly(ethylene imine). Macromol Biosci 2007, 7:968-974.
11. Zhou Y., Huang W., Liu J., Zhu X., Yan D. Self-assembly of hyperbranched polymers and its biomedical applications. Adv Mater 2010, 22:4567-4590.
12. Jin H., Huang W., Zhu X., Zhou Y., Yan D. Biocompatible or biodegradable hyperbranched polymers: from self-assembly to cytomimetic applications. Chem Soc Rev 2012, 41:5986-5997.
13. Chen C.Y., Kim T.H., Wu W.C., Huang C.M., Wei H., Mount C.W., et al. pH-dependent, thermosensitive polymeric nanocarriers for drug delivery to solid tumors. Biomaterials 2013, 34:4501-4509.
14. Onaca O., Enea R., Hughes D.W., Meier W. Stimuli-responsive polymersomes as nanocarriers for drug and gene delivery. Macromol Biosci 2009, 9:129-139.
15. Pavlukhina S., Sukhishvili S. Polymer assemblies for controlled delivery of bioactive molecules from surfaces. Adv Drug Deliv Rev 2011, 63:822-836.
16. Shen Y., Zhan Y., Tang J., Xu P., Johnson P.A., Radosz M., et al. Multifunctioning pH-responsive nanoparticles from hierarchical self-assembly of polymer brush for cancer drug delivery. AIChE J 2008, 54:2979-2989.
17. Zhang C.Y., Yang Y.Q., Huang T.X., Zhao B., Guo X.D., Wang J.F., et al. Self-assembled pH-responsive MPEG-b-(PLA-co-PAE) block copolymer micelles for anticancer drug delivery. Biomaterials 2012, 33:6273-6283.
18. Rofstad E.K., Mathiesen B., Kindem K., Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 2006, 66:6699-6707.
19. Vaupel P. Metabolic microenvironment of tumor cells: a key factor in malignant progression. Exp Oncol 2010, 32:125-127.
20. Zhou K., Wang Y., Huang X., Luby-Phelps K., Sumer B.D., Gao J. Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells. Angew Chem Int Ed Engl 2011, 50:6109-6114.
21. Kolter T., Sandhoff K. Lysosomal degradation of membrane lipids. FEBS Lett 2010, 584:1700-1712.
22. Zhu L.J., Tu C.L., Zhu B.S., Su Y., Pang Y., Yan D.Y., et al. Construction and application of pH-triggered cleavable hyperbranched polyacylhydrazone for drug delivery. Polym Chem 2011, 2:1761-1768.
23. Schonn I., Hennesen J., Dartsch D.C. Ku70 and Rad51 vary in their importance for the repair of doxorubicin- versus etoposide-induced DNA damage. Apoptosis 2011, 16:359-369.
24. Dozier J.H., Hiser L., Davis J.A., Thomas N.S., Tucci M.A., Benghuzzi H.A., et al. Beta class II tubulin predominates in normal and tumor breast tissues. Breast Cancer Res 2003, 5:R157-R169.
25. Zhu L., Shi Y., Tu C., Wang R., Pang Y., Qiu F., et al. Construction and application of a pH-sensitive nanoreactor via a double-hydrophilic multiarm hyperbranched polymer. Langmuir 2010, 26:8875-8881.
26. Zhao X., Poon Z., Engler A.C., Bonner D.K., Hammond P.T. Enhanced stability of polymeric micelles based on postfunctionalized poly(ethylene glycol)-b-poly(γ-propargyl L-glutamate): the substituent effect. Biomacromolecules 2012, 13:1315-1322.
27. Xu Q., Sun Q., Zhang J., Yu J., Chen W., Zhang Z. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer. Carcinogenesis 2013, 34:539-549.
28. Zhang F., Liu J., Lin B., Liu Q., Zhao Y., Zhu L., et al. Increase in docetaxel-resistance of ovarian carcinoma-derived RMG-1 cells with enhanced expression of Lewis Y antigen. Int J Mol Sci 2011, 12:7323-7334.
29. Gerweck L.E., Vijayappa S., Kozin S. Tumor pH controls the invivo efficacy of weak acid and base chemotherapeutics. Mol Cancer Ther 2006, 5:1275-1279.
30. Prescott D.M., Charles H.C., Sostman H.D., Page R.L., Thrall D.E., Moore D., et al. Manipulation of intra- and extracellular pH in spontaneous canine tumours by use of hyperglycaemia. Int J Hyperth 1993, 9:745-754.
31. van Tellingen O., Beijnen J.H., Verweij J., Scherrenburg E.J., Nooijen W.J., Sparreboom A. Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice. Clin Cancer Res 1999, 5:2918-2924.
32. Chen C., Yu C.H., Cheng Y.C., Yu P.H., Cheung M.K. Biodegradable nanoparticles of amphiphilic triblock copolymers based on poly(3-hydroxybutyrate) and poly(ethylene glycol) as drug carriers. Biomaterials 2006, 27:4804-4814.
33. Zhang G., Zhang M.Z., He J.L., Ni P.H. Synthesis and characterization of a new multifunctional polymeric prodrug paclitaxel-polyphosphoester-folic acid for targeted drug delivery. Polym Chem 2013, 4:4515-4525.
34. Cheng J., Wang J. Syntheses of amphiphilic biodegradable copolymers of poly(ethyl ethylene phosphate) and poly(3-hydroxybutyrate) for drug delivery. Sci China Ser B Chem 2012, 52:961-968.
35. Martin-Herranz A., Ahmad A., Evans H.M., Ewert K., Schulze U., Safinya C.R. Surface functionalized cationic lipid-DNA complexes for gene delivery: PEGylated lamellar complexes exhibit distinct DNA-DNA interaction regimes. Biophys J 2004, 86:1160-1168.
36. Immordino M.L., Dosio F., Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 2006, 1:297-315.
37. Kulkarni S.A., Feng S.S. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm Res 2013, [Epub ahead of print].
38. Cho K., Wang X., Nie S., Chen Z.G., Shin D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008, 14:1310-1316.
39. Savic R., Luo L., Eisenberg A., Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 2003, 300:615-618.
40. Shuai X., Ai H., Nasongkla N., Kim S., Gao J. Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. JControl Release 2004, 98:415-426.
41. Danhier F., Feron O., Préat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. JControl Release 2010, 148:135-146.
42. Ndolo R.A., Jacobs D.T., Forrest M.L., Krise J.P. Intracellular distribution-based anticancer drug targeting: exploiting a lysosomal acidification defect associated with cancer cells. Mol Cell Pharmacol 2010, 2:131-136.
43. Stern S.T., Adiseshaiah P.P., Crist R.M. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol 2012, 9:20.
44. Panyam J., Zhou W.Z., Prabha S., Sahoo S.K., Labhasetwar V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 2002, 16:1217-1226.
45. Soppimath K.S., Liu L.H., Seow W.Y., Liu S.Q., Powell R., Chan P., et al. Multifunctional core/shell nanoparticles self-assembled from pH-induced thermosensitive polymers for targeted intracellular anticancer drug delivery. Adv Funct Mater 2007, 17:355-362.
46. Ibsen S., Zahavy E., Wrasdilo W., Berns M., Chan M., Esener S. Anovel Doxorubicin prodrug with controllable photolysis activation for cancer chemotherapy. Pharm Res 2010, 27:1848-1860.
47. Neuberger T., Schöpf B., Hofmann H., Hofmannc M., von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. JMagn Magn Mater 2005, 293:483-496.